Knott David M Jr Incyte Corp Transaction History

Knott David M Jr

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$67.18 - $84.11 $920,366 - $1.15 Million	-13,700 Reduced 84.27%	2,557 $205,000
Q3 2022 Nov 10, 2022	SELL	$66.18 - $82.86 $1.82 Million - $2.28 Million	-27,563 Reduced 62.9%	16,257 $1.08 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $66,020 - $79,710	1,000 Added 2.34%	43,820 $3.48 Million
Q4 2021 Feb 11, 2022	BUY	$63.34 - $74.11 $2.71 Million - $3.17 Million	42,820 New	42,820 $3.14 Million

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

Stay updated on Knott David M Jr with notifications on news.